Suven Life Sciences Limited Right Issue
Closed
BSE, NSE
| Last Date to Buy Shares | — |
| Record Date | Tue, Oct 18, 2022 |
| Credit of Rights Entitlements | Fri, Oct 28, 2022 |
| Bid/Offer Opens On | Mon, Oct 31, 2022 |
| Issue Open Date | Mon, Oct 31, 2022 |
| Renunciation Last Date | Thu, Nov 3, 2022 |
| Bid/Offer Closes On | Thu, Nov 10, 2022 |
| Issue Close Date | Thu, Nov 10, 2022 |
| Deemed Date of Allotment | Fri, Nov 18, 2022 |
| Credit Date | Mon, Nov 21, 2022 |
| Listing Date | Thu, Nov 24, 2022 |
| Issue Size (Shares) | 72,691,239 |
| Issue Size (Amount) | ₹399.80 Cr. |
| Issue Price | ₹55.00 per share |
| Face Value | ₹1.00 per share |
| Entitlement Ratio | — |
| Listing At | BSE, NSE |
| Terms of Payment | ₹55 per share payable in full at the time of application. |
| Period Ended | 2022-03-31 | 2021-03-31 | FY I |
|---|---|---|---|
| Income | 17.16 | 21.23 | — |
| EBITDA | — | — | — |
| Net Worth | — | — | — |
| Reserves & Surplus | — | — | — |
Amount in ₹ Crore
| # | Object | Est. Amount (₹ Cr.) |
|---|---|---|
| 1 | Meeting costs related to pharmaceutical research & development and clinical trial for molecules in the research pipelines. | — |
| 2 | Repayment of an inter-corporate deposit availed by the Company. | — |
| 3 | . General corporate purposes. | — |
| Company | Suven Life Sciences Limited |
| Address | 8-2-334, SDE Serene Chambers, 6th Floor Road No.5, Avenue 7, Banjara Hills, Hyderabad – 500 034 Hyderabad, Telangana, 500034 |
| Phone | 91 40 2354 1142 |
| info@suven.com | |
| Website | Visit ↗ |
| Name | Kfin Technologies Ltd. |
| Phone | 040-79615565 |
| suven.rights@kfintech.com | |
| Website | Visit ↗ |